BRAF mutated
Interviews and expert commentary tagged “BRAF mutated” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Elena Elez, Barcelona, ASCO: BRAF Inhibitor Encorafenib Delays Progression, Extends Survival in Patients with Inoperable BRAF V600E Mutant Colorectal Cancer
An interview with: Elena Elez MD PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain CHICAGO, USA—Adding the BRAF inhibitor encorafenib (partnered with EGFR-inhibitor cetuximab) to standa
19 June 2025
15:34